Novo Nordisk AS (MEX:NVON)
MXN 850.02 +2.02 (+0.24%) Market Cap: 3.76 Tn Enterprise Value: 4.09 Tn PE Ratio: 11.70 PB Ratio: 7.01 GF Score: 76/100

Q1 2022 Novo Nordisk A/S Earnings Presentation - London Transcript

May 05, 2022 / 12:15PM GMT
Release Date Price: MXN1160

May 05, 2022 / 12:15PM GMT
Presentation - London
May 05, 2022 / 12:15PM GMT

=====================
Corporate Participants
=====================
* Camilla Sylvest
Novo Nordisk A/S - Executive VP, Head of Commercial Strategy & Corporate Affairs and Member of the Management Board
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP, CFO & Member of the Management Board
* Martin Holst Lange
Novo Nordisk A/S - Executive VP, Head of Development & Member of the Management Board

=====================
Conference Call Participants
=====================
* Jo Walton
Crédit Suisse AG, Research Division - MD
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst
* Peter Verdult
Citigroup Inc., Research Division - MD
* Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals Analyst
* Richard Vosser
JPMorgan Chase & Co,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot